Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19
Rohitash Yadav, Jitendra Kumar Chaudhary, Neeraj Jain, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 821-821
Open Access | Times Cited: 385

Showing 1-25 of 385 citing articles:

The glycosylation in SARS-CoV-2 and its receptor ACE2
Yanqiu Gong, Suideng Qin, Lunzhi Dai, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 172
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Sam M. Murray, M. Azim Ansari, John Frater, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 5, pp. 304-316
Open Access | Times Cited: 122
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 67
From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World
Mickensone Andre, Lee-Seng Lau, Marissa D. Pokharel, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1267-1267
Open Access | Times Cited: 55
Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications
Aakriti Dubey, Shweta Choudhary, Pravindra Kumar, et al.
Current Microbiology (2021) Vol. 79, Iss. 1
Open Access | Times Cited: 72
Accelerating COVID-19 Research Using Molecular Dynamics Simulation
Aditya K. Padhi, Soumya Lipsa Rath, Timir Tripathi
The Journal of Physical Chemistry B (2021) Vol. 125, Iss. 32, pp. 9078-9091
Closed Access | Times Cited: 67
Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates
Liliana Rodrigues, Renata Bento Cunha, Tatiana Vassilevskaia, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2723-2723
Open Access | Times Cited: 66
Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects
Zhan Zhang, Qi Shen, Haocai Chang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 59
Bioactive Compounds from Mangosteen (Garcinia mangostana L.) as an Antiviral Agent via Dual Inhibitor Mechanism against SARSCoV- 2: An In Silico Approach
ANM Ansori, VD Kharisma, Arli Aditya Parikesit, et al.
Pharmacognosy Journal (2022) Vol. 14, Iss. 1, pp. 85-90
Open Access | Times Cited: 58
In silico investigation of phytoconstituents of medicinal herb ‘Piper Longum’ against SARS-CoV-2 by molecular docking and molecular dynamics analysis
Shradha Lakhera, Kamal Devlal, Arabinda Ghosh, et al.
Results in Chemistry (2021) Vol. 3, pp. 100199-100199
Open Access | Times Cited: 57
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
Sujay Paul, Luis Alberto Bravo-Vázquez, Paula Reyes‐Pérez, et al.
Virus Research (2021) Vol. 308, pp. 198631-198631
Open Access | Times Cited: 57
Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone
Haihai Jiang, Peiyao Yang, Jin Zhang
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 43
Mechanisms of COVID-19 pathogenesis in diabetes
Chandrakala Aluganti Narasimhulu, Dinender K. Singla
AJP Heart and Circulatory Physiology (2022) Vol. 323, Iss. 3, pp. H403-H420
Open Access | Times Cited: 43
SARS‐CoV‐2 Papain‐Like Protease: Structure, Function and Inhibition
Sven Ullrich, Christoph Nitsche
ChemBioChem (2022) Vol. 23, Iss. 19
Open Access | Times Cited: 43
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
José F. Varona, Pedro Landete, José A. López-Martín, et al.
Life Science Alliance (2022) Vol. 5, Iss. 4, pp. e202101200-e202101200
Open Access | Times Cited: 40
Cross-species transmission, evolution and zoonotic potential of coronaviruses
Qian Li, Taif Shah, Binghui Wang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 12
Open Access | Times Cited: 24
Redefining NSP12 activity in SARS-CoV-2 and its regulation by NSP8 and NSP7
Deepa Singh, Tushar Kushwaha, Rajkumar Kulandaisamy, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102452-102452
Open Access | Times Cited: 1
Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants
Deepali Gupta, Priyanka Sharma, Mandeep Singh, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 24, pp. 7967-7989
Open Access | Times Cited: 51
Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets
Rittibet Yapasert, Patompong Khaw-on, Ratana Banjerdpongchai
Molecules (2021) Vol. 26, Iss. 24, pp. 7459-7459
Open Access | Times Cited: 50
An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama–Kohara
Viruses (2021) Vol. 13, Iss. 11, pp. 2302-2302
Open Access | Times Cited: 48
Interactions of the Receptor Binding Domain of SARS-CoV-2 Variants with hACE2: Insights from Molecular Docking Analysis and Molecular Dynamic Simulation
İsmail Çeli̇k, Rohitash Yadav, Zekeriya Düzgün, et al.
Biology (2021) Vol. 10, Iss. 9, pp. 880-880
Open Access | Times Cited: 46
ORF3a Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Inhibits Interferon-Activated Janus Kinase/Signal Transducer and Activator of Transcription Signaling via Elevating Suppressor of Cytokine Signaling 1
Rong Wang, Xiaofeng Yang, Mingke Chang, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 44
Severity, Pathogenicity and Transmissibility of Delta and Lambda Variants of SARS-CoV-2, Toxicity of Spike Protein and Possibilities for Future Prevention of COVID-19
Mehrnoosh Moghaddar, Ramtin Radman, Ian Macreadie
Microorganisms (2021) Vol. 9, Iss. 10, pp. 2167-2167
Open Access | Times Cited: 44
Basic virology of SARS-CoV 2
V. Ravi, Sonal Saxena, Pragyan Swagatika Panda
Indian Journal of Medical Microbiology (2022) Vol. 40, Iss. 2, pp. 182-186
Open Access | Times Cited: 36
A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time
Nasruddeen Al‐Awwal, Ferris Dweik, Samira Mahdi, et al.
Pathogens (2022) Vol. 11, Iss. 3, pp. 368-368
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top